Identification of Urinary Modified Nucleosides and Ribosylated Metabolites in Humans Via Combined ESI-FTICR MS and ESI-IT MS Analysis

Journal of the American Society for Mass Spectrometry

Volumn 19, Issue 10, 2008, Pages 1500-1513

  Bullinger, Dino ^a   Fux, Richard ^a   Nicholson, Graeme ^b   Plontke, Stefan ^a   Belka, Claus ^a   Laufer, Stefan ^b   Gleiter, Christoph H ^a   Kammerer, Bernd ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; FOURIER TRANSFORMS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METABOLITES; NUCLEOTIDES; PHYSIOLOGICAL MODELS; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; THIN LAYER CHROMATOGRAPHY;

BIOLOGICAL FLUIDS; BORONATE; ESI-FTICR; FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY; FTICR-MS; HEAD-AND-NECK CANCER; HUMAN BODIES; ION TRAP-MASS SPECTROMETRY; METABOLIC DISORDERS; METABOLIC PROFILING; MODIFIED NUCLEOSIDES; PHYSIOLOGICAL RESPONSES; PRE-PURIFICATION; RELATED COMPOUNDS; SAMPLE PREPARATION PROCEDURE; TURNOVER RATE;

BIOMOLECULES;

1 RIBOSYL 1 METHYL LEVO HISTIDINIUM; 1 RIBOSYL 3 HYDROXYPYRIDINIUM; 1 RIBOSYL N W ACETYLHISTAMINE; 1 RIBOSYL N W BUTRYLHISTAMINE; 1 RIBOSYL N W CAPROYLHISTAMINE; 1 RIBOSYL N W PHENYLACETYLHISTAMINE; 1 RIBOSYL N W PROPIONYLHISTAMINE; 1 RIBOSYL N W VALERYLHISTAMINE; 1 RIBOSYL PYRIDINIUM; HISTIDINE; METHIONINE; NICOTINAMIDE; NICOTINIC ACID; NUCLEOSIDE; POLYAMINE; UNCLASSIFIED DRUG;

ARTICLE; BODY FLUID; CHEMICAL STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FRAGMENTATION REACTION; HEAD AND NECK CANCER; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ION TRAP MASS SPECTROMETRY; LUNG CANCER; METABOLITE; NUCLEIC ACID ANALYSIS; PURINE SYNTHESIS; RECTUM CANCER; RNA METABOLISM; URINALYSIS;

BIOGENIC POLYAMINES; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FEMALE; FOURIER ANALYSIS; HEAD AND NECK NEOPLASMS; HISTAMINE; HUMANS; LUNG NEOPLASMS; MALE; METHIONINE; NEOPLASMS; NICOTINIC ACIDS; NUCLEOSIDES; PURINES; PYRIDINIUM COMPOUNDS; RECTAL NEOPLASMS; RIBOSE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 53149121631     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2008.06.015     Document Type: Article

References (41)

1. Paik S. Incorporating Genomics into the Cancer Clinical Trial Process. Semin. Oncol. 28 (2001) 305-309
2. Kim S.Y., and Hahn W.C. Cancer Genomics: Integrating Form and Function. Carcinogenesis 28 (2007) 1387-1392
3. Rajapakse J.C., Duan K., and Yeo W.K. Proteomic Cancer Classification with Mass Spectrometry Data. Am. J. Pharmacogenomics 5 (2005) 281-292
4. Maurya P., Meleady P., Dowling P., and Clynes M. Proteomic Approaches for Serum Biomarker Discovery in Cancer. Anticancer Res. 27 (2007) 1247-1255
5. Griffin J.L., and Shockcor J.P. Metabolic Profiles of Cancer Cells. Nat. Rev. Cancer 4 (2004) 551-561
6. Kind T., Tolstikov V., Fiehn O., and Weiss R.H. A Comprehensive Urinary Metabolomic Approach for Identifying Kidney Cancer. Anal. Biochem. 363 (2007) 185-195
7. Gamache P.H., Meyer D.F., Granger M.C., and Acworth I.N. Metabolomic Applications of Electrochemistry/Mass Spectrometry. J. Am. Soc. Mass Spectrom. 15 (2004) 1717-1726
8. Ryan D., and Robards K. Metabolomics: The greatest Omics of Them All?. Anal. Chem. 78 (2006) 7954-7958
9. Tormey D.C., Waalkes T.P., and Gehrke C.W. Biological Markers in Breast Carcinoma-Clinical Correlations with Pseudouridine, N2,N2-Dimethylguanosine, and 1-Methylinosine. J. Surg. Oncol. 14 (1980) 267-273
10. Itoh K., Konno T., Sasaki T., Ishiwata S., Ishida N., and Misugaki M. Relationship of Urinary Pseudouridine and 1-Methyladenosine to Activity of Leukemia and Lymphoma. Clin. Chim. Acta 206 (1992) 181-189
11. Nakano K., Shindo K., Yasaka T., and Yamamoto H. Reversed-Phase High-Performance Liquid Cchromatographic Investigation of Mucosal Nucleosides and Bases and Urinary Modified Nucleosides of Gastrointestinal Cancer Patients. J. Chromatogr. 343 (1985) 21-33
12. Waalkes T.P., Abeloff M.D., Ettinger D.S., Woo K.B., Gehrke C.W., Kuo K.C., and Borek E. Modified Ribonucleosides as Biological Markers for Patients with Small Cell Carcinoma of the Lung. Eur. J. Cancer Clin. Oncol. 18 (1982) 1267-1274
13. Borek E., Baliga B.S., Gehrke C.W., Kuo C.W., Belman S., Troll W., and Waalkes T.P. High Turnover Rate of Transfer RNA in Tumor Tissue. Cancer Res. 37 (1977) 3362-3366
14. Tsutsui E., Srinivasan P.R., and Borek E. TRNA Methylases in Tumors of Animal and Human Origin. Proc. Natl. Acad. Sci. U.S.A. 56 (1966) 1003-1009
15. Dudley E., Lemiere F., Van Dongen W., Langridge J.I., El-Sharkawi S., Games D.E., Esmans E.L., and Newton R.P. Analysis of Urinary Nucleosides. III. Identification. of 5′-Deoxycytidine in Urine of a patient with head and neck cancer. Rapid Commun. Mass Spectrom. 17 (2003) 1132-1136
16. Gehrke C.W., and Kuo K.C. Ribonucleoside Analysis by Reversed-Phase High-Performance Liquid Chromatography. J. Chromatogr. 471 (1989) 3-36
17. Xu G., Schmid H.R., Lu X., Liebich H.M., and Lu P. Excretion Pattern Investigation of Urinary Normal and Modified Nucleosides of Breast Cancer Patients by RP-HPLC and Factor Analysis Method. Biomed. Chromatogr. 14 (2000) 459-463
18. Xu G., Lu X., Zhang Y., Lu P., Di S.C., Lehmann R., and Liebich H. Two Approaches for Determining the Urinary Excretion Patterns of Nucleosides-HPLC and CE. Sepu 17 (1999) 97-101
19. Kammerer B., Frickenschmidt A., Muller C.E., Laufer S., Gleiter C.H., and Liebich H. Mass Spectrometric Identification of Modified Urinary Nucleosides Used as Potential Biomedical Markers by LC-ITMS Coupling. Anal. Bioanal. Chem. 382 (2005) 1017-1026
20. Qian M., Yang S., Wu H., Majumdar P., Leigh N., and Glaser R. Ammonia Elimination from Protonated Nucleobases and Related Synthetic Substrates. J. Am. Soc. Mass. Spectrom. 18 (2007) 2040-2057
21. Zhang Q., and Wang Y. Differentiation of 2′-O- and 3′-O-Methylated Ribonucleosides by Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 17 (2006) 1096-1099
22. Takeda N., Nakamura M., Yoshizumi H., and Tatematsu A. Structural Characterization of Modified Nucleosides in tRNA Hydrolysates by Frit-Fast Atom Bombardment Liquid Chromatography/Mass Spectrometry. Biol. Mass Spectrom. 23 (1994) 465-474
23. Crow F.W., Tomer K.B., Gross M.L., McCloskey J.A., and Bergstrom D.E. Fast Atom Bombardment Combined with Tandem Mass Spectrometry for the Determination of Nucleosides. Anal. Biochem. 139 (1984) 243-262
24. Bullinger D., Frickenschmidt A., Pelzing M., Zey T., Zurek G., Laufer S., and Kammerer B. Identification of Urinary Nucleosides by ESI-TOF-MS. LC-GC Eur. (2005) 16-17
25. Kammerer B., Frickenschmidt A., Gleiter C.H., Laufer S., and Liebich H. MALDI-TOF MS Analysis of Urinary Nucleosides. J. Am. Soc. Mass Spectrom. 16 (2005) 940-947
26. McCloskey J.A., and Crain P.F. The RNA Modification Database-1998. Nucleic Acids Res. 26 (1998) 196-197
27. Bullinger D., Neubauer H., Fehm T., Laufer S., Gleiter C.H., and Kammerer B. Metabolic Signature of Breast Cancer Cell Line MCF-7: Profiling of Modified Nucleosides via LC-IT MS Coupling. BMC Biochem. 8 (2007) 25
28. Liebich H.M., Di S.C., Wixforth A., and Schmid H.R. Quantitation of Urinary Nucleosides by High-Performance Liquid Chromatography. J. Chromatogr. A 763 (1997) 193-197
29. Barcelo-Barrachina E., Moyano E., and Galceran M.T. Determination of Heterocyclic Amines by Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry. J. Chromatogr. A 1054 (2004) 409-418
30. 2O Adduct Formation and Gas-Phase Reactions in the Collision Cell. J. Am. Soc. Mass Spectrom. 16 (2005) 1291-1304
31. Frycak P., Huskova R., Adam T., and Lemr K. Atmospheric Pressure Ionization Mass Spectrometry of Purine and Pyrimidine Markers of Inherited Metabolic Disorders. J. Mass Spectrom. 37 (2002) 1242-1248
32. Chheda G.B., Patrzyc H.B., Tworek H.A., and Dutta S.P. Isolation and Characterization of 5-Carbamoylmethyluridine and 5-Carbamoylmethyl-2-Thiouridine from Human Urine. Nucleosides Nucleotides 18 (1999) 2155-2173
33. Chheda G.B., Tworek H.A., Bhargava A.K., Rachlin E., Dutta S.P., and Patrzyc H.B. Isolation and Characterization of 3-(3-Amino-3-Carboxypropyl)Uridine from Human Urine. Nucleosides Nucleotides 7 (1988) 417-429
34. Imamura I., Watanabe T., Sakamoto Y., Wakamiya T., Shiba T., Hase Y., Tsuruhara T., and Wada H.N. τ-Ribosylhistidine, a Novel Histidine Derivative in Urine of Histidinemic Patients. Isolation, Structure, and Tissue Level. J. Biol. Chem. 260 (1985) 10528-10530
35. Piraud M., Vianey-Saban C., Petritis K., Elfakir C., Steghens J., Morla A., and Bouchu D. ESI-MS/MS Analysis of Underivatized Amino Acids: A New Tool for the Diagnosis of Inherited Disorders of Amino Acid Metabolism. Fragmentation Study of 79 Molecules of Biological Interest in Positive and Negative Ionization mode. Rapid Commun. Mass Spectrom. 17 (2003) 1297-1311
36. van der Heiden C., Wadman S.K., de Bree P.K., and Wauters E.A. Increased Urinary Imidazolepropionic acid, N-Acetylhistamine, and Other Imidazole Compounds in Patients with Intestinal Disorders. Clin. Chim. Acta 39 (1972) 201-214
37. van der Heiden C., Wauters E.A., Duran M., Wadman S.K., and Ketting D. Gas Chromatographic Analysis of Urinary Tyrosine and Phenylalanine Metabolites in Patients with Gastrointestinal Disorders. Clin. Chim. Acta 34 (1971) 289-296
38. Morris G.S., Simmonds H.A., and Davies P.M. Use of Biological Fluids for the Rapid Diagnosis of Potentially Lethal Inherited Disorders of Human Purine and Pyrimidine Metabolism. Biomed. Chromatogr. 1 (1986) 109-118
39. Schram K.H. Urinary Nucleosides. Mass Spectrom. Rev. 17 (1998) 131-251
40. Chheda G.B. Isolation and Characterization of N6-Succinyladenosine from Human Urine. Nucleic Acids Res. 4 (1977) 739-746
41. Mills J.S., Mills G.C., and McAdoo D.J. Isolation and Identification of 5′-Methylthioadenosine Sulfoxide from Human Urine. Nucleosides Nucleotides 2 (1983) 465-478